IDIOPATHIC INFLAMMATORY MYOPATHY
Clinical trials for IDIOPATHIC INFLAMMATORY MYOPATHY explained in plain language.
Never miss a new study
Get alerted when new IDIOPATHIC INFLAMMATORY MYOPATHY trials appear
Sign up with your email to follow new studies for IDIOPATHIC INFLAMMATORY MYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radical cell therapy trial targets incurable autoimmune diseases
Disease control Recruiting nowThis early-stage study is testing a new cell therapy called CC-97540 for people with severe autoimmune diseases that haven't responded to multiple treatments. The therapy involves collecting a patient's own immune cells, engineering them to target specific immune cells (B cells),…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company • Aim: Disease control
Last updated Apr 01, 2026 19:56 UTC
-
One-Shot cell therapy aims to reset immune system in devastating muscle diseases
Disease control Recruiting nowThis study is testing a one-time cell therapy called CABA-201 for adults and children with rare autoimmune diseases that cause severe muscle weakness and inflammation. The goal is to see if this treatment can safely reduce disease activity and improve muscle strength, potentially…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY
Phase: PHASE2, PHASE3 • Sponsor: Cabaletta Bio • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists test 'Living Drug' to reset the immune system in lupus and related diseases
Disease control Recruiting nowThis is a first-in-human study testing the safety and early effectiveness of a new type of cell therapy called ALLO-329 in adults with severe autoimmune diseases like lupus, myositis, and scleroderma. The therapy involves giving patients specially engineered immune cells (CAR T c…
Matched conditions: IDIOPATHIC INFLAMMATORY MYOPATHY
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC